Scand J Clin Lab Invest. 1951;3(3):201-8.

The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.

OWREN PA, AAS K.

PMID:: 14900966; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Coumarins

Substances

LinkOut - more resources

Full Text Sources

Molecular Biology Databases

COUMARIN - HSDB

Supplemental Content

Related citations

Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin. [Acta Med Scand. 1954]
Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
LUND E, DYGGVE H. Acta Med Scand. 1954; 150(4):271-5.
COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT. [Calif Med. 1963]
COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.
REILLY EB, GOODMAN JR, WARNER GF. Calif Med. 1963 Oct; 99:234-5.
[Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity]. [Ugeskr Laeger. 1955]
[Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
IVERSEN T. Ugeskr Laeger. 1955 Jul 7; 117(27):873-8.
Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method. [Acta Med Scand. 1956]
Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method.
IVERSEN T. Acta Med Scand. 1956 Sep 6; 155(3):161-70.
Review Current pharmacogenetic developments in oral anticoagulation therapy: the influence of variant VKORC1 and CYP2C9 alleles. [Thromb Haemost. 2007]
Review Current pharmacogenetic developments in oral anticoagulation therapy: the influence of variant VKORC1 and CYP2C9 alleles.
Oldenburg J, Bevans CG, Fregin A, Geisen C, Müller-Reible C, Watzka M. Thromb Haemost. 2007 Sep; 98(3):570-8.

See reviews... See all...

Cited by 62 PubMed Central articles

"Premarin" as a Haemostatic Agent: Failure to Demonstrate Any Laboratory or Clinical Effect. [Br Med J. 1960]
"Premarin" as a Haemostatic Agent: Failure to Demonstrate Any Laboratory or Clinical Effect.
Borchgrevink CF, Andersen R, Hall J, Hatteland K, Ursin-Holm A. Br Med J. 1960 Dec 3; 2(5213):1645-7.
Blood Coagulation and Fibrinolysis in Relation to Coronary Heart Disease. [Br Med J. 1960]
Blood Coagulation and Fibrinolysis in Relation to Coronary Heart Disease.
Merskey C, Gordon H, Lackner H, Schrire V, Kaplan BJ, Sougin-Mibashan R, Nossel HL, Moodie A. Br Med J. 1960 Jan 23; 1(5168):219-27.
Megaloblastic anaemia associated with phenobarbital therapy. [Can Med Assoc J. 1960]
Megaloblastic anaemia associated with phenobarbital therapy.
SHERWIN AL, WAIT RH, COOPER BA. Can Med Assoc J. 1960 Feb 13; 82:368-70.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The control of dicumarol therapy and the quantitative determination of prothromb...
The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.
Scand J Clin Lab Invest. 1951 ;3(3):201-8.

PubMed
European Concerted Action on Anticoagulation. Correction of displayed internatio...
European Concerted Action on Anticoagulation. Correction of displayed international normalized ratio on two point-of-care test whole-blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent international sensitivity index calibration.
Br J Haematol. 2003 Sep ;122(6):944-9.

PubMed
Poor agreement among prothrombin time international normalized ratio methods: co...
Poor agreement among prothrombin time international normalized ratio methods: comparison of seven commercial reagents.
Clin Chem. 2005 Mar ;51(3):553-60. Epub 2005 Jan 21 .

PubMed
Interference of lupus anticoagulants in prothrombin time assays: implications fo...
Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Haematologica. 1999 Dec ;84(12):1065-74.

PubMed
Has the time arrived to replace the quick prothrombin time test for monitoring o...
Has the time arrived to replace the quick prothrombin time test for monitoring oral anticoagulant therapy?
Clin Chem. 2005 Mar ;51(3):483-5.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Molecular Biology Databases

Supplemental Content

Related citations

Cited by 62 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information